ProCE Banner Activity

Preview of ASH 2017: Key Expert-Selected Studies

Conference Coverage
Clinical Thought
Experts highlight key data to help you learn what to expect at the upcoming Hematology meeting in Atlanta. The CCO ASH Conference Coverage program will feature downloadable slides and expert analysis of these and dozens of other clinically relevant studies presented at ASH. We will have the information you need to understand and integrate the latest hematology data into your practice.

Released: December 06, 2017

Share

Faculty

Christopher W. Ryan

Christopher W. Ryan, MD

Assistant Professor of Medicine
Division of Hematology & Medical Oncology
Oregon Health and Science University
Portland, Oregon

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

AbbVie

AstraZeneca

Celgene

Genentech TEXT Only

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals Inc

Novartis Pharmaceuticals Corporation

Pharmacyclics Inc

Seagen

Takeda Oncology

Faculty Disclosure

Primary Author

Christopher W. Ryan, MD

Assistant Professor of Medicine
Division of Hematology & Medical Oncology
Oregon Health and Science University
Portland, Oregon

Christopher R. Flowers, MD, has disclosed that he has served as a consultant for AbbVie, Bayer, Celgene (unpaid), Genetech/Roche (unpaid), Gilead Sciences, Karyopharm, Pharmacyclics/Janssen, and Spectrum and has received funds for research support from AbbVie, Acerta, Celgene, Gilead Sciences, Genentech/Roche, Janssen, Millennium/Takeda, Pharmacyclics, and TG Therapeutics.